Literature DB >> 12196532

Vasopressin-dependent inhibition of the C-type natriuretic peptide receptor, NPR-B/GC-B, requires elevated intracellular calcium concentrations.

Sarah E Abbey1, Lincoln R Potter.   

Abstract

Natriuretic peptides bind their cognate cell surface guanylyl cyclase receptors and elevate intracellular cGMP concentrations. In vascular smooth muscle cells, this results in the activation of the type I cGMP-dependent protein kinase and vasorelaxation. In contrast, pressor hormones like arginine-vasopressin, angiotensin II, and endothelin bind serpentine receptors that interact with G(q) and activate phospholipase Cbeta. The products of this enzyme, diacylglycerol and inositol trisphosphate, activate the conventional and novel forms of protein kinase C (PKC) and elevate intracellular calcium concentrations, respectively. The latter response results in vasoconstriction, which opposes the actions of natriuretic peptides. Previous reports have shown that pressor hormones inhibit natriuretic peptide receptors NPR-A or NPR-B in a variety of different cell types. Although the mechanism for this inhibition remains unknown, it has been universally accepted that PKC is an obligatory component of this pathway primarily because pharmacologic activators of PKC mimic the inhibitory effects of these hormones. Here, we show that in A10 vascular smooth muscle cells, neither chronic PKC down-regulation nor specific PKC inhibitors block the AVP-dependent desensitization of NPR-B even though both processes block PKC-dependent desensitization. In contrast, the cell-permeable calcium chelator, BAPTA-AM (1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid, tetraacetoxymethyl ester), abrogates the AVP-dependent desensitization of NPR-B, and ionomycin, a calcium ionophore, mimics the AVP effect. These data show that the inositol trisphosphate/calcium arm of the phospholipase C pathway mediates the desensitization of a natriuretic peptide receptor in A10 cells. In addition, we report that CNP attenuates AVP-dependent elevations in intracellular calcium concentrations. Together, these data reveal a dominant role for intracellular calcium in the reciprocal regulation of these two important vasoactive signaling systems.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196532     DOI: 10.1074/jbc.M206686200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Mass spectrometric identification of phosphorylation sites in guanylyl cyclase A and B.

Authors:  Andrea R Yoder; Matthew D Stone; Timothy J Griffin; Lincoln R Potter
Journal:  Biochemistry       Date:  2010-11-08       Impact factor: 3.162

2.  The linker region in receptor guanylyl cyclases is a key regulatory module: mutational analysis of guanylyl cyclase C.

Authors:  Sayanti Saha; Kabir Hassan Biswas; Chandana Kondapalli; Nishitha Isloor; Sandhya S Visweswariah
Journal:  J Biol Chem       Date:  2009-07-31       Impact factor: 5.157

3.  Dephosphorylation and inactivation of NPR2 guanylyl cyclase in granulosa cells contributes to the LH-induced decrease in cGMP that causes resumption of meiosis in rat oocytes.

Authors:  Jeremy R Egbert; Leia C Shuhaibar; Aaron B Edmund; Dusty A Van Helden; Jerid W Robinson; Tracy F Uliasz; Valentina Baena; Andreas Geerts; Frank Wunder; Lincoln R Potter; Laurinda A Jaffe
Journal:  Development       Date:  2014-09       Impact factor: 6.868

4.  Prolonged atrial natriuretic peptide exposure stimulates guanylyl cyclase-a degradation.

Authors:  Darcy R Flora; Lincoln R Potter
Journal:  Endocrinology       Date:  2010-04-09       Impact factor: 4.736

5.  Catalytically Active Guanylyl Cyclase B Requires Endoplasmic Reticulum-mediated Glycosylation, and Mutations That Inhibit This Process Cause Dwarfism.

Authors:  Deborah M Dickey; Aaron B Edmund; Neil M Otto; Thomas S Chaffee; Jerid W Robinson; Lincoln R Potter
Journal:  J Biol Chem       Date:  2016-03-15       Impact factor: 5.157

6.  The indolocarbazole, Gö6976, inhibits guanylyl cyclase-A and -B.

Authors:  Jerid W Robinson; Xiaoying Lou; Lincoln R Potter
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

7.  ATP potentiates competitive inhibition of guanylyl cyclase A and B by the staurosporine analog, Gö6976: reciprocal regulation of ATP and GTP binding.

Authors:  Jerid W Robinson; Lincoln R Potter
Journal:  J Biol Chem       Date:  2011-08-02       Impact factor: 5.157

8.  Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs.

Authors:  Naohisa Tamura; Lynda K Doolittle; Robert E Hammer; John M Shelton; James A Richardson; David L Garbers
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-30       Impact factor: 11.205

Review 9.  Central role of guanylyl cyclase in natriuretic peptide signaling in hypertension and metabolic syndrome.

Authors:  G Martel; P Hamet; Johanne Tremblay
Journal:  Mol Cell Biochem       Date:  2009-11-25       Impact factor: 3.396

10.  Novel bifunctional natriuretic peptides as potential therapeutics.

Authors:  Deborah M Dickey; John C Burnett; Lincoln R Potter
Journal:  J Biol Chem       Date:  2008-10-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.